Literature DB >> 26055589

Characteristics of 22q 11.2 deletion syndrome undiagnosed until adulthood: an example suggesting the importance of psychiatric manifestations.

Kenta Furuya1, Yosuke Sasaki1, Taizo Takeuchi1, Yoshihisa Urita1.   

Abstract

Patients with chromosome 22q11.2 deletion syndrome (22q11.2DS) exhibit various combinations of signs and symptoms including facial dysmorphism, thymus absence, hypoparathyroidism, cellular immunodeficiency and cardiac abnormalities caused by microdeletion of chromosome 22q11.2. Most cases are diagnosed during post-natal cardiac evaluation, though some are diagnosed at later stages. We report the case of a 39-year-old man with 22q11.2DS presenting with seizure due to tardily manifested hypocalcaemia and anxiety disorder. Our experience suggests that 22q11.2DS patients lacking fatal or well-recognised manifestations such as cardiac defects, immunodeficiency and facial dysmorphism tend to survive without medical attention, and are therefore overlooked. Recognition of the age-related variance of the manifestations, and specifically of tardily manifested hypocalcaemia and psychiatric or developmental disorders as manifestations of 22q11.2DS in adulthood, is important for diagnosis and can also help us provide appropriate medical and psychosocial support for newly diagnosed 22q11.2DS patients in adolescence or adulthood and their families. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26055589      PMCID: PMC4460410          DOI: 10.1136/bcr-2014-208903

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  18 in total

1.  Latent hypoparathyroidism in children with conotruncal cardiac defects.

Authors:  B F Cuneo; C B Langman; M N Ilbawi; V Ramakrishnan; A Cutilletta; D A Driscoll
Journal:  Circulation       Date:  1996-05-01       Impact factor: 29.690

2.  Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research.

Authors:  John P Bilezikian; Aliya Khan; John T Potts; Maria Luisa Brandi; Bart L Clarke; Dolores Shoback; Harald Jüppner; Pierre D'Amour; John Fox; Lars Rejnmark; Leif Mosekilde; Mishaela R Rubin; David Dempster; Rachel Gafni; Michael T Collins; Jim Sliney; James Sanders
Journal:  J Bone Miner Res       Date:  2011-10       Impact factor: 6.741

Review 3.  Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

Authors:  Donna M McDonald-McGinn; Kathleen E Sullivan
Journal:  Medicine (Baltimore)       Date:  2011-01       Impact factor: 1.889

4.  Partial DiGeorge syndrome at the age of thirty-four.

Authors:  A Hirotani; S Morimoto; E Koh; T Ogihara
Journal:  Intern Med       Date:  1994-07       Impact factor: 1.271

5.  Di-George syndrome presenting with hypocalcaemia in adulthood: two case reports and a review.

Authors:  P S Kar; B Ogoe; R Poole; D Meeking
Journal:  J Clin Pathol       Date:  2005-06       Impact factor: 3.411

Review 6.  Anti-parathyroid and anti-calcium sensing receptor antibodies in autoimmune hypoparathyroidism.

Authors:  Edward M Brown
Journal:  Endocrinol Metab Clin North Am       Date:  2009-06       Impact factor: 4.741

7.  Transient congenital hypoparathyroidism: resolution and recurrence in chromosome 22q11 deletion.

Authors:  F Greig; E Paul; J DiMartino-Nardi; P Saenger
Journal:  J Pediatr       Date:  1996-04       Impact factor: 4.406

8.  Symptomatic hypoparathyroidism based on a 22q11 deletion first diagnosed in a 43-year-old woman.

Authors:  K van den Berge; K Diderich; P Poddighe; A Berghout
Journal:  Neth J Med       Date:  2009-03       Impact factor: 1.422

Review 9.  Prenatal diagnosis of the 22q11.2 deletion syndrome.

Authors:  D A Driscoll
Journal:  Genet Med       Date:  2001 Jan-Feb       Impact factor: 8.822

10.  Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study.

Authors:  A K Ryan; J A Goodship; D I Wilson; N Philip; A Levy; H Seidel; S Schuffenhauer; H Oechsler; B Belohradsky; M Prieur; A Aurias; F L Raymond; J Clayton-Smith; E Hatchwell; C McKeown; F A Beemer; B Dallapiccola; G Novelli; J A Hurst; J Ignatius; A J Green; R M Winter; L Brueton; K Brøndum-Nielsen; P J Scambler
Journal:  J Med Genet       Date:  1997-10       Impact factor: 6.318

View more
  4 in total

1.  Parkinson's disease with hypocalcaemia: adult presentation of 22q11.2 deletion syndrome.

Authors:  Fradique Moreira; Ana Brás; Joana Ramos Lopes; Cristina Januário
Journal:  BMJ Case Rep       Date:  2018-03-22

2.  An Adult Case of Chromosome 22q11.2 Deletion Syndrome Associated with a High-positioned Right Aortic Arch.

Authors:  Yoichi Hoshino; Moriya Machida; Shun-Ichi Shimano; Teizo Taya
Journal:  Intern Med       Date:  2017-04-01       Impact factor: 1.271

3.  Pediatric healthcare costs for patients with 22q11.2 deletion syndrome.

Authors:  Peter Benn; Sushma Iyengar; Terrence Blaine Crowley; Elaine H Zackai; Evanette K Burrows; Solomon Moshkevich; Donna M McDonald-McGinn; Kathleen E Sullivan; Zachary Demko
Journal:  Mol Genet Genomic Med       Date:  2017-08-12       Impact factor: 2.183

Review 4.  EDUCATIONAL SERIES IN CONGENITAL HEART DISEASE: Prenatal diagnosis of congenital heart disease.

Authors:  Lindsey E Hunter; Anna N Seale
Journal:  Echo Res Pract       Date:  2018-07-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.